HBIO
Harvard Bioscience Inc
stockNASDAQ
harvard bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. we sell our products to thousands of researchers in over 100 countries through our full-line catalog (and various other specialty catalogs), our websites, and through distributors, including ge healthcare, thermo fisher scientific inc., and vwr. we have sales and manufacturing operations in the united states, the united kingdom, germany, and spain and sales facilities in france and canada.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 8.67 | 2026-11-03 | +3.21% | 0.967 |
| 1M | 8.24 | 2026-10-09 | +8.60% | 1.027 |
| 3M | 6.39 | 2026-08-10 | +40.04% | 0.791 |
| 6M | 6.84 | 2026-05-11 | +30.83% | 0.694 |
| 1Y | 5.81 | 2025-11-10 | +53.97% | 1.428 |
| 2Y | 24.50 | 2024-11-11 | -63.48% | — |
| 5Y | 75.30 | 2021-11-10 | -88.12% | 1.345 |
Harvard Bioscience Inc (NASDAQ:HBIO) stock price today is $8.95, and today's volume is 53,179. HBIO is down 1.555% today. The 30 day average volume is 20,236. HBIO market cap is $40.74M with 4.55M shares outstanding.